Value proposition

Aptissen delivers orthobiologic solutions to joint medical specialists.

Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com

The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors'​ network among more than 90 countries including Europe, South America, Canada, Middle East and Asia.

Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com

We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.

Osteoarthritis, Orthopaedic, Rheumatology, Joint pain, Viscosupplement, Hyaluronic Acid, and Injectable